Dornase alfa en es it fr

Dornase alfa Brand names, Dornase alfa Analogs

Dornase alfa Brand Names Mixture

  • No information avaliable

Dornase alfa Chemical_Formula

C1321H1999N339O396S9

Dornase alfa RX_link

http://www.rxlist.com/cgi/generic3/pulmozyme.htm

Dornase alfa fda sheet

Dornase alfa msds (material safety sheet)

Dornase alfa Synthesis Reference

No information avaliable

Dornase alfa Molecular Weight

29253.9

Dornase alfa Melting Point

67 oC (Chan, H.K. et al., Pharm Res. 13:756-761 (1996))

Dornase alfa H2O Solubility

No information avaliable

Dornase alfa State

Liquid

Dornase alfa LogP

-0.083

Dornase alfa Dosage Forms

Solution

Dornase alfa Indication

For treatment of cystic fibrosis

Dornase alfa Pharmacology

Cystic fibrosis (CF) is a disease characterized by the retention of viscous purulent secretions in the airways. These thick secretions contribute both to reduced pulmonary function and to frequent pulmonary infection. Purulent pulmonary secretions contain very high concentrations of extracellular DNA released by degenerating leukocytes that accumulate in response to these infections. Pulmozyme hydrolyzes the DNA in sputum of CF patients and reduces sputum viscoelasticity.

Dornase alfa Absorption

No information avaliable

Dornase alfa side effects and Toxicity

No information avaliable

Dornase alfa Patient Information

BIOD00001.html

Dornase alfa Organisms Affected

Humans and other mammals